Abstract:Background: The brain atrophy in individual Alzheimer's disease (AD) patients includes not only specific atrophy from AD pathology, but also atrophy induced by normal aging and cerebral vascular diseases. Although medial temporal lobe atrophy (MTA) together with CSF biomarkers is suggested to be the most important diagnostic markers for AD, it may not be specific. The current method of choice to measure MTA has been volumetric measurement based on 3D magnetic resonance imaging (MRI), but this complicated method has not been implemented clinically. Female sex has been suggested to be a risk factor for AD. The left hippocampus may be more vulnerable in AD. Atrophy of hippocampus has also been found to emerge in healthy adults, along with increased age. Purposes: To investigate whether simple Computerized Tomography (CT) linear measurements of brain could be of value in AD work-up; to create a normative database of hippocampus volume in our large population-based study and to examine if there is an acceleration of hippocampal atrophy in normal aging; to examine the hippocampal and entorhinal cortex volumes in relation to vascular risk factors. Material and Methods: In the CT study (Papers 1&2), 59 controls, 162 pure AD, and 86 AD with minor cerebrovascular changes (CVC) between the ages of 52 and 94 years were recruited from the Malmo Alzheimer Study. Abeta42, T-tau and P-tau in CSF were examined. CT linear measurements were performed, which included temporal horn ratio and suprasellar cistern ratio that reflect MTA. In the MRI study (Papers 3&4), 544 healthy non-demented subjects (aged 60-97 years) were recruited from the Swedish National study of Aging and Care in Kungsholmen (SNAC-K). Hippocampal formation and entorhinal cortex were manually delineated. Semi-automatic tools were used to access the volume of 3rd, lateral ventricle and intracranial volume (ICV). Vascular risk factors were collected. Results: In the CT study (Papers 1&2), temporal horn ratio and suprasellar cistern ratio were the atrophy factors that contributed most significantly to the diagnoses with correct AD classification of 90.2%. The correct classification of AD+CVC from controls increased from 79.5% (only CSF biomarkers) to 84.6% (combined CT measurements with CSF biomarkers). However, little was changed in the pure AD group. In the MRI study (Papers 3&4), The normalized volumes of hippocampus in males were smaller than that in females. The right hippocampus was larger than the left. The rate of aging atrophy trend (AAT) for the expansion of ventricles was larger than the estimated hippocampal shrinkage. The age point (72y) was shown to represent the time when the acceleration of AAT in hippocampus starts in normal aging. The score of vascular risk factors was significantly associated with reduced volumes of hippocampus and entorhinal cortex only among men. Conclusions: CT linear measurements could be of value in work-up of AD patients. Combined with the CT measure of MTA, the specificity of CSF biomarkers can be increased, but only in AD+CVC. In a non-demented elderly population, the females were more vulnerable to hippocampal atrophy. An acceleration of hippocampal atrophy may emerge and start around 72 years of age. An increasing burden of vascular risk factors is associated with reduced volume of hippocampus and entorhinal cortex.

Magnitude and kinetics of a set of neuroanatomic volume and thickness together with white matter hyperintensity is definitive of cognitive status and brain age

Impact of Different White Matter Hyperintensities Patterns on Cognition: A Cross-Sectional and Longitudinal Study.

DIFFERENTIAL GREY AND WHITE MATTER MICROSTRUCTURAL ABNORMALITIES IN EARLY AND LATE-ONSET ALZHEIMER’S DISEASE AND MILD COGNITIVE IMPAIRMENT

Periventricular and Deep White Matter Hyperintensity Thresholds in Aging: Exponential Progression, Cognitive Decline, and Neuroanatomic Atrophy

Distinct Atrophy Pattern of Hippocampal Subfields in Patients with Progressive and Stable Mild Cognitive Impairment: A Longitudinal MRI Study

Regional Quantification of White Matter Hyperintensity in Normal Aging, Mild Cognitive Impairment, and Alzheimer’s Disease

Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD

Topographical differences in white matter hyperintensity burden and cognition in aging, MCI, and AD

Cerebrovascular lesion loads and accelerated brain aging: insights into the cognitive spectrum

Association of white matter hyperintensities with cognitive decline and neurodegeneration

White matter hyperintensity distribution differences in aging and neurodegenerative disease cohorts

Associations of White Matter Hyperintensities with Cognitive Decline: A Longitudinal Study

Structural Mri Biomarkers of Mild Cognitive Impairment from Young Elders to Centenarians

THE CUMULATIVE SPATIAL DISTRIBUTION OF WHITE MATTER HYPERINTENSITIES AND ITS CRITICAL STAGE THAT AFFECTS COGNITION AND THE BRAIN IN NON-DEMENTED ELDERLY

Voxel-based Morphometry of Amnestic Mild Cognitive Impairment and Alzheimer's Disease

P3‐060: Voxel‐based Morphometry of Amnestic Mild Cognitive Impairment and Alzheimer's Disease

Brain MRI and CT Morphology in Healthy Aging and Alzheimer's Disease

Cerebral Microbleeds, Cerebral Amyloid Angiopathy, and Their Relationships to Quantitative Markers of Neurodegeneration

In vivo microstructural heterogeneity of white matter and cognitive correlates in aging using tissue compositional analysis of diffusion magnetic resonance imaging

White matter brain age as a biomarker of cerebrovascular burden in the ageing brain

P2‐049: Reduced Functional Hippocampal Connectivity Associates with Gray Matter Volume Loss in Mild Cognitive Impairment and Alzheimer's Disease Subjects